These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 11982448

  • 21. Intramuscular aripiprazole in the control of agitation.
    Currier GW, Citrome LL, Zimbroff DL, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [Abstract] [Full Text] [Related]

  • 22. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients.
    San L, Arranz B, Querejeta I, Barrio S, De la Gándara J, Pérez V.
    Eur Psychiatry; 2006 Dec; 21(8):539-43. PubMed ID: 16697151
    [Abstract] [Full Text] [Related]

  • 23. Calming versus sedative effects of intramuscular olanzapine in agitated patients.
    Battaglia J, Lindborg SR, Alaka K, Meehan K, Wright P.
    Am J Emerg Med; 2003 May; 21(3):192-8. PubMed ID: 12811711
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT.
    J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
    [Abstract] [Full Text] [Related]

  • 25. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD, Sanger TM.
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [Abstract] [Full Text] [Related]

  • 26. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

  • 27. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
    Walther S, Moggi F, Horn H, Moskvitin K, Abderhalden C, Maier N, Strik W, Müller TJ.
    J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
    [Abstract] [Full Text] [Related]

  • 28. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, McQuade RD.
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [Abstract] [Full Text] [Related]

  • 29. Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients.
    Barak Y, Shamir E, Zemishlani H, Mirecki I, Toren P, Weizman R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1199-202. PubMed ID: 12452546
    [Abstract] [Full Text] [Related]

  • 30. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder.
    Centorrino F, Meyers AL, Ahl J, Cincotta SL, Zun L, Gulliver AH, Kinon BJ, Houston JP.
    Hum Psychopharmacol; 2007 Oct; 22(7):455-62. PubMed ID: 17708578
    [Abstract] [Full Text] [Related]

  • 31. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB.
    J Clin Psychiatry; 1997 Oct; 58 Suppl 10():45-9. PubMed ID: 9265916
    [Abstract] [Full Text] [Related]

  • 32. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
    Hsu WY, Huang SS, Lee BS, Chiu NY.
    J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
    [Abstract] [Full Text] [Related]

  • 33. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ, Stauffer VL, Kollack-Walker S, Chen L, Sniadecki J.
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [Abstract] [Full Text] [Related]

  • 34. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV, Dellva MA, Tollefson GD, Beasley CM, Potvin JH, Kiesler GM.
    J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614
    [Abstract] [Full Text] [Related]

  • 35. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
    Carlson CD, Cavazzoni PA, Berg PH, Wei H, Beasley CM, Kane JM.
    J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
    [Abstract] [Full Text] [Related]

  • 36. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.
    J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
    [Abstract] [Full Text] [Related]

  • 37. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
    MacDonald K, Wilson M, Minassian A, Vilke GM, Becker O, Tallian K, Cobb P, Perez R, Galangue B, Feifel D.
    J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
    [Abstract] [Full Text] [Related]

  • 38. Treatment of agitation in the acute psychiatric setting. An observational study of the effectiveness of intramuscular psychotropic medication.
    Bauer JØ, Stenborg D, Lodahl T, Mønsted MM.
    Nord J Psychiatry; 2016 Nov; 70(8):599-605. PubMed ID: 27284637
    [Abstract] [Full Text] [Related]

  • 39. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
    Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM, HGDH Study Group.
    Am J Psychiatry; 2003 Aug; 160(8):1396-404. PubMed ID: 12900300
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.